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Kingdom; and Department of Neurology (R.B.), University Medical Centre Ljubljana, Zaloska cesta 2,
1000 Ljubljana, Slovenia
Context: Polycystic ovary syndrome (PCOS) is a disorder characterized by insulin resistance and
hyperandrogenism, which leads to an increased risk of type 2 diabetes in later life. Androgens and
insulin signaling affect brain function but little is known about brain structure and function in
younger adults with PCOS.
Objective: To establish whether young women with PCOS display altered white matter micro-
structure and cognitive function.
Patients, interventions, and main outcome measures: Eighteen individuals with PCOS (age, 31 
6 y; bodymass index [BMI] 30 6 kg/m2) and 18 control subjects (age, 31 7 y; BMI, 29 6 kg/m2),
matched for age, IQ, and BMI, underwent anthropometric and metabolic evaluation, diffusion
tensor MRI, a technique especially sensitive to brain white matter structure, and cognitive assess-
ment. Cognitive scores andwhitematter diffusionmetricswere compared betweengroups.White
matter microstructure was evaluated across the whole white matter skeleton using tract-based
spatial statistics. Associations with metabolic indices were also evaluated.
Results: PCOS was associated with a widespread reduction in axial diffusivity (diffusion along the
main axis of white matter fibers) and increased tissue volume fraction (the proportion of volume
filled by white or grey matter rather than cerebrospinal fluid) in the corpus callosum. Cognitive
performance was reduced compared with controls (first principal component, t  2.9, P  .007),
reflecting subtle decrements across a broad range of cognitive tests, despite similar education and
premorbid intelligence. In PCOS, there was a reversal of the relationship seen in controls between
brain microstructure and both androgens and insulin resistance.
Conclusions:White matter microstructure is altered, and cognitive performance is compromised,
in young adults with PCOS. These alterations in brain structure and function are independent of
age, education and BMI. If reversible, these changes represent a potential target for treatment.
(J Clin Endocrinol Metab 101: 314–323, 2016)
The precursors of late-life cognitive decline can betracedback tomidadult life.Risk states inmiddle age
include behavioral factors (eg, smoking), aspects of car-
diovascular function (eg, hypertension and cardiac struc-
ture) and metabolic traits. Metabolic factors shown to
confer risk in cohort studies include diabetes and predia-
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betes: in the Framingham Offspring Study, individuals
with prediabetes and diabetes had smaller brain volumes
and poorer cognitive performance, especially on tests of
executive function and visual memory (1), comparedwith
those with normal glucose regulation. Adiposity, indexed
by body mass index (BMI), has also been associated with
subsequent dementia (2, 3).
Polycystic ovary syndrome (PCOS) is characterized by
a high prevalence of obesity, hyperandrogenism and in-
sulin resistance, leading to an increased risk of type 2 di-
abetes mellitus. An unfavorable metabolic profile persists
after menopausal transition as a result of increased an-
drogen levels and decreased estrogen levels with further
exacerbation of insulin resistance, chronic inflammation
and adiposity (4). There have been few investigations of
the effect of PCOS on the brain. One internet-based study
compared neuropsychological functioning in right-
handed women with and without PCOS, finding no evi-
dence of an effect of hyperandrogenism or hyperestro-
genism on cognitive function (5). One other study
described poorer performance on tests of verbal fluency,
verbal memory, manual dexterity, and visuospatial work-
ing memory in PCOS, but importantly, the comparison
group of healthy women was not matched for BMI (6).
Some early evidence suggests that metabolic risk states
may have an influence onbrain structure.Diffusion tensor
magnetic resonance imaging (MRI) is a technique that is
sensitive to the structure and organization of whitematter
in the brain, providing unprecedented insight into the or-
ganization of white matter fibers and tracts. Furthermore,
it provides quantitative indices of white matter micro-
structure. Diffusion tensor MRI studies have shown how
whitemattermicrostructure evolves in the developing and
ageing brain and have also revealed subtle damage in early
cognitive decline and in association with vascular risk
states. Both type 1 and type 2 diabetes are associated with
altered microstructural measures derived from diffusion
tensor MRI (7–9). Several studies have now shown asso-
ciations between BMI and white matter microstructure
(10–12). Furthermore, in type 2 diabetes, alterations in
tract microstructure have been found to correlate with
cognitive performance (7). A common difficulty in inter-
preting these studies is that metabolic features tend to
occur in clustered syndromes, for example,metabolic syn-
drome, rather than as isolated abnormalities. Conse-
quently, the critical factors thatmost influencebrain struc-
ture and function are unclear. This is also true of previous
cognitive studies in PCOS that might have been con-
founded by BMI (6). Defining the main factors that drive
end-organ damage in the brain is crucial to the construc-
tion of preventative strategies. Carefully controlled stud-
ies, that isolate 1 or a small group of factors, have a role
that is complementary to large cohort studies in identify-
ing specific features ormechanisms thatmight be targeted.
The current study investigated brain structure and cog-
nitive function in women in early adulthood with a diag-
nosis of PCOS. To investigate the effects of metabolic dis-
turbances specific to PCOS, a control groupwas recruited
that was carefully matched for BMI, the main potential
confounder, as well as age and premorbid intelligence.
Materials and Methods
Participants
Patients with PCOS (n  18, 16 Caucasian and 2 Afro-Ca-
ribbean) were recruited from the endocrine clinic at the Univer-
sity Hospital of Wales. Diagnosis was according to the Rotter-
dam criteria (13). Congenital adrenal hyperplasia, Cushing’s
syndrome, androgen-secreting neoplasms, hyperprolactinemia
and thyroid disease were excluded by biochemical testing. Pa-
tients were between 18 and 45 years of age.Metabolic exclusion
criteria were: pregnancy and breastfeeding, hyperlipidemia or
use of lipid-lowering agents, diabetes or use of antidiabetic
drugs, and use of antiandrogens within 6 months. Neurological
exclusion criteria included: previousor currentmajorpsychiatric
illness, clinical cerebrovascular disease, previous severe head in-
jury, hypertension, and current substance and alcohol abuse.
Healthy volunteers (n 18, all Caucasian) were recruited as
controls with 1 to 1 matching for age and BMI. For each indi-
vidual patient, a control was identified matched for age (within
2 y) and BMI (within 2 kg/m2). Controls needed to have regular
menstrual cycles (menses every 27–32 d). Control subjects with
signs of hirsutism or with a personal history of diabetes or hy-
pertension, or a family history of PCOS were excluded. Control
subjects were recruited by advertisement among students and
staff within the School of Medicine and University Hospital of
Wales. Their health status was determined by history, physical
examination and hormonal evaluation (testosterone, andro-
stenedione, thyroid function, prolactin, and 17-hydroxyproges-
terone). The study was approved by Cardiff University (study
sponsors), Cardiff and Vale University Health Board and the
South East Wales Research Ethics Committee. All subjects gave
written, informed consent.
Anthropometric and biochemical measurements
Height, weight, waist and hip circumference were measured
according to our previously published protocol (14). Blood pres-
sure was measured at the brachial artery of the right arm using
a validated semiautomated oscillometric device (Omron 705IT;
Omron Corp) after 10 minutes of rest in the seated position; an
average of 3 readings taken over a 10-minute period was
recorded.
Blood samples were collected after an overnight fast. Serum
total cholesterol, high density lipoprotein cholesterol and trig-
lycerides were assayed using an Aeroset analyzer (Abbott Diag-
nostics); lowdensity lipoprotein cholesterolwas calculatedusing
Friedewald’s formula. Insulin was measured using an immuno-
metric assay specific for human insulin (Invitron), and glucose
was measured using the Aeroset chemistry system (Abbott Di-
agnostics). High sensitivity C-reactive protein (CRP) was as-
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sayed by nephelometry (BN II system; Dade Behring), and total
testosterone was measured by liquid chromatography-tandem
mass spectrometry (Quattro Premier XE triple quadrupole tan-
dem mass spectrometer; Waters Ltd). Androstenedione was
measured by immunoassay (SiemensHealthcare). The intra- and
interassay coefficients of variation were all less than 9%.
A standard 75-g oral glucose tolerance test was performed in
all participants. Glucose and insulin were measured at 0, 30, 60,
90, and 120 minutes. The areas under the curve (AUCs) for
insulin and glucose were calculated using the trapezoid method.
Cognitive testing
A set of cognitive tests was devised based on previous liter-
ature on cognitive dysfunction in metabolic disorders (15, 16)
and that included tests of episodic memory, attentional, and ex-
ecutive function. Premorbid IQwas estimatedwith theNational
Adult Reading Test Revised and current IQ estimated with the
Wechsler abbreviated scale of intelligence (WASI). Short-term
and working memory were assessed with Digit Span. Episodic
memory was assessed by the Free and Cued Selective Reminding
test (17) and the Rey Osterrieth Complex figure. Tests sensitive
to attention and executive function included Verbal Trails, Digit
Symbol Substitution, Stroop Color-Word Association Test, let-
ter and semantic fluency (with letters “FAS” and the category
“animals,” respectively). The Beck depression inventory was
also administered.
MRI data acquisition
MRI was performed on a 3T GE HDxMRI system (General
Electric). Diffusion imageswere acquiredwith a twice-refocused
spin-echo echo planar imaging sequence, providing whole
oblique axial (parallel to the commissural plane) brain coverage.
Data acquisition were peripherally gated to the cardiac cycle.
Data were acquired for 60 slices of 2.4 mm in thickness, with a
field of viewof 23 cmand an acquisitionmatrix of 9696. Echo
timewas 87milliseconds and parallel imaging (array spatial sen-
sitivity encoding factor  2) was used. The b-value was 1200
s/mm2. In each imaging session, data were acquired with diffu-
sion encoded along 30 isotropically distributed directions and 3
nondiffusion-weighted scans, according to an optimized gradi-
ent vector scheme (18). Fluid attenuated inversion recovery scans
were also obtained. Acquisition time was 19 minutes.
Images were visually inspected for the presence of white mat-
ter hyperintensities.On this basis, 2 subjectswere excluded from
further analysis.
Diffusion metrics and tract-based spatial statistics
(TBSS)
Diffusion-weighted images were corrected for eddy current
and motion distortion using the ExploreDTI software package
(19). Diffusion tensor images were then corrected to remove the
effects of cerebrospinal fluid contaminationusing the FreeWater
Elimination approach (20). Maps of the next microstructural
measureswere then created. Fractional anisotropy (FA) is amea-
sure of the directionality of diffusion, commonly used in diffu-
sionMRI research studies. FA is high in white matter, especially
in major tracts in which axons are packed in a coherent, parallel
fashion. It is also increased by the presence of axonalmembranes
or myelin sheaths that hinder diffusion. Disruption of this co-
herent organization or loss of axons or myelin generally reduce
FA and increase mean diffusivity (MD), a measure of diffusion
averaged in all spatial directions. Axial diffusivity (AD) is amea-
sure of diffusion taken along the principal axis of diffusion (usu-
ally assumed to be the orientation of fibers in a white matter
tract). Radial diffusivity (RD) is a measure of diffusion perpen-
dicular to this principal axis. Some have argued that AD is more
sensitive to axonal factors andRDmore sensitive tomyelination
but their precise biophysical correlates are not known. Tissue
volume fraction (f) represents the proportion of a voxel that is
composed of gray or white matter (as opposed to cerebrospinal
fluid). One simplified interpretation of this measure would be to
view it as ameasure of atrophy at a small (microstructural) scale.
All measures were calculated as previously described (21).
The above steps produced diffusion measurements at each
voxel (imaging element) in the brain. To comparemeasurements
across the PCOS and control groups, these images were all
mapped to a single template. This allows measures to be com-
pared voxel by voxel (described as “voxel-based analysis”), with
the problem of comparisons across many voxels addressed by
one of a number of statistical approaches that are widely ac-
cepted in neuroimaging research. The advantage of this ap-
proach is that it is free of a priori bias about the likely location
of structural alteration in the brain. TBSS is a widely accepted
approach for statistical analysis of diffusion data and was im-
plemented in this study. TBSS is part of the FMRIB Software
Library image analysis software (Centre for Functional MRI of
the Brain, University ofOxford, http://www.fmrib.ox.ac.uk/fsl/,
version 5.0) (22). Using TBSS, microstructural measures from
the presumed tract centers of each participant were estimated.
First, the recommended FMRIB58_FA standard-space image
was used as the registration target for each subject’s FA maps.
The aligned FA data were then projected to the mean FA skel-
eton. Voxel projections defined in this waywere applied to proj-
ect voxel values of MD, AD, RD, and f to the white matter
skeleton for each subject. Resulting skeletonized data were used
to generate voxelwise statistical analyses.
Statistical analysis
Principal components analysis was used to generate an un-
biased composite measure of cognitive scores. Principal compo-
nentswere derived from the next tests:Digit Span, Free andCued
Selective Reminding test, Rey Osterrieth Complex figure test,
Verbal Trails, Digit Symbol Substitution and the letter and se-
mantic fluency test. The first principal component, which ac-
counted for 35% of the variance across all test scores, was used
as a summary score and compared across the 2 groups using an
unpaired t test. A threshold of significance of 0.05 was used for
this single comparison. Subsequent comparisons for individual
test scores were performed. These were exploratory, so only un-
corrected P values are provided.
ForTBSS, 2-sample unpaired t tests for reduced and increased
diffusion measures in PCOS patients compared with controls
were performed. Additionally, microstructural measures were
correlated with the value of the first principal component and
hormonal levels in each group separately. Statistical inference
was based on nonparametric permutation: 5000 permutations
were performed using randomize software (23). Resulting sta-
tistical maps were thresholded for P  .05, corrected for fami-
lywise error, by implementing threshold-free cluster enhance-
ment (24).
In the absence of any previous data in subjectswith PCOS,we
basedour sample size calculations ondata fromaprevious study,
316 Rees et al White Matter Microstructure and PCOS J Clin Endocrinol Metab, January 2016, 101(1):314–323
The Endocrine Society. Downloaded from press.endocrine.org by [${individualUser.displayName}] on 25 May 2016. at 02:15 For personal use only. No other uses without permission. . All rights reserved.
which examined the influence of BMI on corpus callosum mi-
crostructure (10). Anticipating a broadly similar effect size, we
calculated that a sample of 18 participants per group would
provide at least 95%power to detect a between-group difference
in FA of 0.05 at the 5% significance level.
Results
Group differences between PCOS and control
participants
Participants in the PCOS group included those with
full-blown (n  8, 44%), non-polycystic ovary (n  1,
6%), nonhyperandrogenic (n  5, 28%), and ovulatory
(n 4, 22%) subphenotypes described by the Rotterdam
criteria. No individual in either group had evidence of
depression based on Beck depression inventory score
(scores all 15). The groups were well matched for pre-
morbid intelligence. Table 1 shows demographic, clinical,
anthropometric, and metabolic characteristics of the 2
groups. The groups were closely matched for age, BMI,
and anthropometric measures. As expected, individuals
with PCOS had raised testosterone and androstenedione
levels compared with controls. Insulin response to oral
glucose challenge (insulin AUC) was higher in those with
PCOS, confirming insulin resistance in this group. Two
subjects in each group were taking a combined oral con-
traceptive pill, and 2 in each group were smokers. Five
subjects in the PCOS group, and 2 controls had predia-
betes (American Diabetes Association criteria), whereas 3
subjects with PCOS and 4 controls had metabolic syn-
drome according to the International Diabetes Federation
definition.
Cognitive performance was degraded in patients with
PCOS compared with controls. For the summary score,
thebetweengroupdifferencewas significant: t2.88,P
.007. Table 2 summarizes performance on underlying in-
dividual cognitive measures.
Analysis of diffusion MRI images revealed differences
inwhitemattermicrostructurebetweenPCOSandcontrol
groups. Areas of decreased AD in PCOS were found
throughout the mean white matter skeleton (Figure 1,
blue). In addition, tissue volume fraction was increased in
the rostral body of the corpus callosum and parts of an-
teriorwhitematter (Figure 1, red) in PCOS. Therewere no
significant differences in voxelwise values of FA, MD, or
RD between the groups.
Insulin resistance and white matter microstructure
Voxelwise correlations between insulin AUC and AD
were not significant in either PCOS or controls. However,
there was a significant group by insulin AUC interaction
(P  .05 corrected with familywise error) (Figure 2A),
suggesting that the relationship between insulin resistance
and white matter microstructure differed in PCOS and
control groups.Toexplore this further,meanvaluesofAD
were extracted from this region andplotted against insulin
AUC (Figure 2B). Increasing insulin resistance was asso-
ciated with reduction of AD in controls (Pearson’s r 
Table 1. Anthropometric and Metabolic Characteristics of the Study Population
PCOS
(n  18, Mean  SD)
Controls
(n  18, Mean  SD) P Value
Age (y) 31  6 31  7 .9
Estimated premorbid intelligence 122  4 121  8 .35
Weight (kg) 78  21 76  15 .68
BMI (kg/m2) 30  6 29  6 .61
Systolic BP (mm Hg) 119  8 120  11 .96
Diastolic BP (mm Hg) 66  8 69  10 .36
Waist (cm) 91  15 86  13 .31
Hip (cm) 111  16 106  12 .24
Visceral fat area (cm2) 31  23 26  14 .46
Subcutaneous fat area (cm2) 287  119 298  114 .78
Total fat area (cm2) 318  133 324  124 .89
Testosterone (nmol/L) 1.6  0.6 0.9  0.6 .01
Androstenedione (nmol/L) 13.4  7.3 6.8  2.5 .001
hsCRP (mg/L) 1.2 (0.2  21.8) 0.9 (0.1  16.7) .73
Total cholesterol (mmol/L) 4.6  1.3 4.8  1.1 .67
Triglycerides (mmol/L) 1.2  1.4 1.0  0.5 .52
LDL cholesterol (mmol/L) 2.4  1.4 2.5  1.3 .79
HDL cholesterol (mmol/L) 1.2  0.5 1.3  0.6 .65
HbA1c (mmol/mol) 34.6  2.9 33.6  4.4 .40
Insulin AUC (pmol min/L) 93 151  42 694 61 933  29 614 .04
Glucose AUC (mmol min/L) 764  217 692  133 .24
Estimation of premorbid intelligence was based on the National Adult Reading Test–Revised. hsCRP, high sensitivity CRP; LDL, low density
lipoprotein; HDL, high density lipoprotein; AUC, AUC during oral glucose tolerance test.
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0.75) but with increasing AD in those with PCOS (Pear-
son’s r  0.73), a reversal of the relationship found in
controls. The reduction in AD found, on average, in pa-
tients with PCOS compared with controls was evident in
thosewith relativelynormal insulinAUC(100 000pmol
min/L) but ADwas increased in a subset of PCOS patients
with marked insulin resistance.
Androgens and white matter microstructure
Serum testosterone correlated positively with both AD
and FA in the PCOS group (Figure 3). No association was
observed in control participants. The direction of effect
was consistent with that found between insulin AUC and
diffusion metrics, ie, increasing values of AD were asso-
ciatedwith both increases in testosterone and insulinAUC
(Figure 2B) in patients with PCOS.
Metabolic status, white matter microstructure, and
cognition in PCOS
We found no correlation between cognitive perfor-
mance and testosterone or insulin AUC in PCOS (testos-
terone: r  0.12, P  .64; insulin AUC: r  0.01, P 
.98). No significant correlations were observed between
microstructuralmeasures and cognition. Similarly, no sig-
nificant associations with cognitive performance were
found in the control group.
Discussion
PCOSwas associated with both subtle decrements of cog-
nitive function and alterations in microstructure of brain
white matter. These differences are not attributable to
BMI, which was closely matched between groups, as was
general intelligence. PCOS is one of the commonest met-
abolic syndromes, affecting up to 10% of women of re-
productive age (25). The public health importance of
PCOS is amplified by the association with other rapidly
growing public health problems, notably type 2 diabetes
and obesity (26). Traditionally, treatment has focused on
managing infertility and reducing cardiovascular risk.The
current results suggest that the potential consequences of
PCOS are wider: the possibility that PCOS represents a
midlife risk state for cognitive decline in old age should be
explored. The case-control design effectively isolated 2
features of PCOS, insulin resistance and hyperandrogen-
emia, as possible causes of the alterations in white matter
structure and cognition that were observed. Attention to
these specific factors would help to define such a risk state
and potential treatments more precisely.
The current findings suggest a subtle but widespread
erosion of cognitive performance. In an internet-based
computerized study, Barnard et al hypothesized that
womenwith PCOSwould display enhanced cognitive per-
formance on sexually dimorphic tasks (5). However, no
differencewas found in performance ofmental rotation or
spatial location tasks. Contrary to expectation, women
with PCOS showed impaired performance on reaction
timeandword recognition tasks. SchattmannandSherwin
similarly found no differences on tests of mental rotation,
spatial visualization, or spatial perception in PCOS (6).
However, subjectswith PCOSperformed lesswell on tests
of verbal fluency, verbal memory, manual dexterity, and
Table 2. Performance on Individual Cognitive Tests
PCOS
(n  18, Mean  SD)
Controls
(n  18, Mean  SD)
P
Value
Intelligence and executive function
Digit span forward 12  1.9 13.6  2.2 .02
Digit span backward 7.4  2.5 9.1  2.3 .04
Digit symbol 83  15.8 90.1  12.5 .14
Verbal trails (switching cost) 44.5  21.2 33.4  9.8 .03
Verbal trails (errors) 1.1  1.5 .55  1.1 .23
Letter fluency 38.1  11 39.1  11 .79
Category fluency 39.6  7.5 44  6.3 .06
Stroop Colour Word test (duration) 118.3  22.7 106.4  20.5 .11
WASI (vocabulary) 64  9.2 69.88  5.5 .02
WASI (block design) 49.1  13.7 56.2  8.9 .07
WASI (similarities) 39.5  4.8 43.61  2.8 .04
WASI (matrix reasoning) 27.1  6.6 27.8  3.2 .7
Episodic memory
FCSRT immediate recall 13.7  1.9 15.4  2.4 .03
FCSRT free recall 35.7  8.9 41.1  8.1 .06
FCSRT total recall 41.7  7.7 44.7  6.1 .20
FCSRT delayed free recall 13.2  2.4 14.9  1.2 .01
FCSRT delayed total recall 15.8  0.4 15.9  0.2 .65
Rey Osterrieth Complex figure 26.7  6.9 30.6  4 .05
FCSRT, Free and Cued Selective Reminding test.
318 Rees et al White Matter Microstructure and PCOS J Clin Endocrinol Metab, January 2016, 101(1):314–323
The Endocrine Society. Downloaded from press.endocrine.org by [${individualUser.displayName}] on 25 May 2016. at 02:15 For personal use only. No other uses without permission. . All rights reserved.
Figure 1. Group differences based on TBSS. A, Mean white matter skeleton voxels showing significantly lower value of AD (blue) and higher
value of tissue volume fraction in PCOS (red) compared with healthy volunteers. Displayed results are corrected for familywise error and
thresholded for P  .05. The white matter skeleton is shown in green. B, Mean values of AD and tissue volume f across parts of the skeleton
showing a significant group difference for each participant.
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visuospatialworkingmemory. Previous studies haveoften
been limited by poor case-control matching. For example,
Barry et al found evidence of better visuospatial task per-
formance in women with PCOS compared with subfertile
controls, but this difference was no longer significant
when age andBMIwere controlled for in the analysis (27).
In parallel with metabolic and cognitive differences,
microstructural alterations in cerebral white matter were
observed in the PCOS group. AD was reduced in a large
portion of the white matter skeleton in PCOS and tissue
volume fraction was increased in the anterior corpus cal-
losum. Intriguingly, similar findings have been reported in
studies on sexual dimorphism. For example, Kumar et al
(28) found widespread reductions of axial and RD values
in the male brain. The corpus callosum is generally larger
in males. Further, a study with myelin-water fraction im-
aging has illustrated increased myelin density in males in
the rostral body and posterior midbody of the corpus cal-
losum (29), possibly concordant with our findings of in-
creased f in the anterior part of the corpus callosum even
though these studies address structural characteristics that
are not necessarily closely correlated. One interpretation
of the findings in the present study, therefore, is that an
influence of androgens on brain structure produces alter-
ations in PCOS that parallel the characteristics of themale
brain.
The finding of a positive association between andro-
gens and ADwithin the PCOS groupwas a surprise, given
evidence that white matter AD is reduced in PCOS. Hy-
perandrogenemia and insulin resistance in the PCOS
Figure 2. Contrasting associations between white matter microstructure and insulin resistance in PCOS and healthy volunteers. A, White matter
skeleton voxels exhibiting a significant group by insulin AUC interaction are shown in red (P  .05 corrected for familywise error). B, Mean AD
values extracted from the region of significant interaction for each participant and plotted against insulin AUC. The direction of association is
positive in PCOS and negative in controls.
320 Rees et al White Matter Microstructure and PCOS J Clin Endocrinol Metab, January 2016, 101(1):314–323
The Endocrine Society. Downloaded from press.endocrine.org by [${individualUser.displayName}] on 25 May 2016. at 02:15 For personal use only. No other uses without permission. . All rights reserved.
groupwere associatedwith increasingAD, despite amean
reduction in the PCOS group as a whole. The likely ex-
planation was a reversal of the normal relationship be-
tween microstructure and metabolic status in patients
withPCOS, reflected in a significant groupby insulinAUC
interaction. These findings raise the possibility that the
brain responds differently to the effect of androgens in
PCOS. Alternatively, there may be significant heteroge-
neity among individuals that is currently not captured by
the coarse diagnostic categories in current use. For exam-
ple, theremaybedistinct subtypes of PCOSwith andwith-
out insulin resistance that differ in a variety of ways that
are not yet fully understood; similarly, the presence of
increased insulin resistance in some BMI-matched con-
trols suggests heterogeneity in the healthy population.
Previous studies have reported differences in diffusion
metrics in both type 2 diabetes (7) and obesity. Type 2
diabetes is associated with increases in AD in a number of
specific tracts. Studies in obesity are less consistent, with
at least 1 study reporting effects that vary by anatomical
location in the brain and include both increases and de-
creases of AD in different regions (12, 30, 31). These re-
ports illustrate that there is no simple relationshipbetween
diffusion measures and better or worse white matter “in-
tegrity” (32). The histological basis of alterations in dis-
ease states remains unclear and furtherwork is required to
aid the interpretation of direction aswell as themagnitude
of effects. Previous epidemiological studies suggest a com-
plex relationship between BMI and dementia risk. Both
high and low body mass states have been associated with
future dementia risk, with evidence that the relationship
might differ in mid and later life (2). One recent report
highlighted this complexity by showing a relationship be-
tween low body weight in midlife and dementia (33) con-
tradicting previously held views about midlife obesity (2,
3). The average age of individuals at entry to this recent
retrospective study was 55; even less is known about the
risk implications of BMI in the twenties and thirties, the
age range relevant to the current study.
There were some limitations to the experimental ap-
proach. Firstly, we selected our PCOS subjects by the Rot-
terdam criteria, which embrace a less severe metabolic
phenotype than other definitions of the syndrome. How-
ever, if anything this might be expected to underestimate
the extentofwhitematter alteration inPCOSsubjectswith
more severehyperandrogenismand insulin resistance.The
Rotterdam criteria also encompass a heterogeneous
group, hence future studies should compare distinct PCOS
phenotypes, including lean subjects alone, in order to es-
tablish whether cognitive function and white matter mi-
crostructure are altered in all PCOS patients or only in
some. Secondly, we did not capture information on phys-
ical activity levels in our study; future studies should look
to record this in view of the possible relationship between
Figure 3. Correlation of testosterone level with microstructural measures in PCOS. White matter skeleton voxels exhibiting a positive correlation
with FA (A) and AD (B) are shown in red. Displayed results are corrected for familywise error and thresholded for P  .05.
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sedentary behavior and cognitive decline. Thirdly, no
clear correlation was found between cognition and white
matter structure of relevant regions or connections. This
related partly to power. Another factor was the unex-
pected interaction between group andmetabolic factors in
their influence on white matter structure.
A key question that follows from these observations is
whether alterations in brain structure and function can be
reversed, reducing the risk of future cognitive decline. In-
terestingly, 1 study in PCOS suggested improvement in a
single cognitive measure (verbal fluency), after combined
treatment with an antiandrogen plus estrogen (34). Based
on the current results, both insulin resistance andhyperan-
drogenism are potential targets, and advancedMRI has a
potential role as a biomarker of treatment effect.
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